Judith Anne Shizuru serves as Executive at Jasper Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Judith Anne Shizuru has executed 2 insider transactions totaling $99.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 22, 2025 involved purchasing 41,000 shares valued at $99.6K.
Judith Anne Shizuru currently holds 156,901 shares of Jasper Therapeutics, Inc. (JSPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Judith Anne Shizuru has been a net buyer of JSPR stock. They have purchased $99.6K and sold $0 worth of shares.
Judith Anne Shizuru's most recent insider trade was on Sep 22, 2025, when they purchased 41,000 shares at $2.43 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |